IVA Stock Summary and Trading Ideas (Inventiva S.A. - American Depository Shares | NASDAQ:IVA)

Inventiva SA is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases with unmet medical needs.

Inventiva S.A. - American Depository Shares trades on the NASDAQ stock market under the symbol IVA.

As of October 9, 2026, IVA stock price declined to $3.16 with 2,671,412 million shares trading.

IVA has a beta of 1.33, meaning it tends to be more sensitive to market movements. IVA has a correlation of 0.04 to the broad based SPY ETF.

IVA has a market cap of $746.46 million. This is considered a Small Cap stock.

Last quarter Inventiva S.A. - American Depository Shares reported $23,251 in Revenue and -$.29 earnings per share. This fell short of revenue expectation by $-10 million and missed earnings estimates by -$.09.

In the last 3 years, IVA traded as high as $7.98 and as low as $1.53.

The top ETF exchange traded funds that IVA belongs to (by Net Assets): MEDI, APIE.

IVA has underperformed the market in the last year with a price return of -42.9% while the SPY ETF gained +17.1%. IVA has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -30.2% and -6.2%, respectively, while the SPY returned +3.8% and +0.9%, respectively.

IVA support price is $3.14 and resistance is $3.50 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IVA shares will trade within this expected range on the day.